PRANA Biotechnology Ltd
Level 1, 100 Dorcas Street
South Melbourne
Victoria
3205
Tel: 61-3-9690-7892
Fax: 61-3-9690-8587
Website: http://www.pranabio.com/
Email: info@pranabio.com
192 articles about PRANA Biotechnology Ltd
-
PRANA Biotechnology Provides Clinical Trials Safety and Progress Update
4/3/2013
-
PRANA Biotechnology Announces Successful $7.3 Million Capital Raising
3/27/2013
-
PRANA Biotechnology Details Data Showing That PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation
3/8/2013
-
PRANA Biotechnology's PBT434 Inhibits Accumulation of Parkinson's Protein and Subsequent Death of Brain Cells
3/6/2013
-
PRANA Biotechnology Announces That PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation
3/4/2013
-
PRANA Biotechnology to Present at Cowen and Company Health Care Conference on March 4th in Boston, MA
2/25/2013
-
PRANA Biotechnology Announces That New York Academy of Sciences eBriefing is Available Online
1/29/2013
-
PRANA Biotechnology Completes Recruitment in Huntington Trial
12/19/2012
-
Journal of Huntington's Disease Publishes Benefits of PRANA Biotechnology's PBT2
12/13/2012
-
PRANA Biotechnology Release: Metal Hypothesis for Alzheimer's, Huntington and Other Neurodegenerative Diseases Declared Promising Therapeutic Strategy by Scientists at New York Academy of Sciences Symposium
12/5/2012
-
PRANA Biotechnology Completes Recruitment in Alzheimer's Trial
11/27/2012
-
PRANA Biotechnology to Present at New York Academy of Sciences Symposium on November 29th
11/20/2012
-
PRANA Biotechnology: Revised Table in 2012 Annual Report
10/8/2012
-
PRANA Biotechnology Announces A$6.0 Million Capital Raising
10/1/2012
-
PRANA Biotechnology Scientist to Participate in Webcast to Discuss Alzheimer's Disease Therapeutics: Recent Setbacks and Emerging Technologies on Monday, October 1
9/28/2012
-
PRANA Biotechnology's PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration From the Metal Equilibrium Perspective
9/20/2012
-
PRANA Biotechnology Receives Recommendation to Proceed With Alzheimer's Clinical Trial From Data Safety Monitoring Board (DSMB)
9/12/2012
-
PRANA Biotechnology Shows Significant Promise in the Fight Against Alzheimer's Disease, According to Experts at Celebration of Science Conference
9/10/2012
-
PRANA Biotechnology Scientists to Participate in Panel on Alzheimer's and Other Issues of Aging at Celebration of Science Conference
9/7/2012
-
PRANA Biotechnology's Parkinson's Drug Meets The Michael J. Fox Foundation Development Milestone
8/29/2012